Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

Friday, Nov 7, 2025 11:03 am ET1min read
CARL--

Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

Truist Securities Raises PT to $20, Reiterates Buy Rating on Carlsmed.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet